We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 09, 2021

Oral Azithromycin Does Not Improve COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection

JAMA: The Journal of the American Medical Association

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA: The Journal of the American Medical Association
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial
JAMA 2021 Jul 16;[EPub Ahead of Print], CE Oldenburg, BA Pinsky, J Brogdon, C Chen, K Ruder, L Zhong, F Nyatigo, CA Cook, A Hinterwirth, E Lebas, T Redd, TC Porco, TM Lietman, BF Arnold, T Doan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading